These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 17473066)
1. Total inhibin is a potential serum marker for epithelial ovarian cancer. Tsigkou A; Marrelli D; Reis FM; Luisi S; Silva-Filho AL; Roviello F; Triginelli SA; Petraglia F J Clin Endocrinol Metab; 2007 Jul; 92(7):2526-31. PubMed ID: 17473066 [TBL] [Abstract][Full Text] [Related]
2. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer. Robertson DM; Stephenson T; Pruysers E; McCloud P; Tsigos A; Groome N; Mamers P; Burger HG J Clin Endocrinol Metab; 2002 Feb; 87(2):816-24. PubMed ID: 11836327 [TBL] [Abstract][Full Text] [Related]
3. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. Healy DL; Burger HG; Mamers P; Jobling T; Bangah M; Quinn M; Grant P; Day AJ; Rome R; Campbell JJ N Engl J Med; 1993 Nov; 329(21):1539-42. PubMed ID: 8413476 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer. Phocas I; Sarandakou A; Sikiotis K; Rizos D; Kalambokis D; Zourlas PA Anticancer Res; 1996; 16(6B):3827-31. PubMed ID: 9042265 [TBL] [Abstract][Full Text] [Related]
5. [Role of total inhibin in diagnosis and monitoring of ovarian cancer in postmenopausal women]. Markova D; Milchev N; Batashki I; Uchikov A Akush Ginekol (Sofiia); 2008; 47(1):16-9. PubMed ID: 18642569 [TBL] [Abstract][Full Text] [Related]
6. Combined inhibin and CA125 assays in the detection of ovarian cancer. Robertson DM; Cahir N; Burger HG; Mamers P; McCloud PI; Pettersson K; McGuckin M Clin Chem; 1999 May; 45(5):651-8. PubMed ID: 10222351 [TBL] [Abstract][Full Text] [Related]
7. Inhibin as a diagnostic marker for ovarian cancer. Robertson DM; Pruysers E; Jobling T Cancer Lett; 2007 Apr; 249(1):14-7. PubMed ID: 17320281 [TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma]. Wang MJ; Qi J; Wang H; Li XX; Wei BJ; Fu C; Gao J; Han BB Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):540-3. PubMed ID: 22093635 [TBL] [Abstract][Full Text] [Related]
10. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy]. Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334 [TBL] [Abstract][Full Text] [Related]
12. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours. Burger HG; Robertson DM; Cahir N; Mamers P; Healy DL; Jobling T; Groome N Clin Endocrinol (Oxf); 1996 Apr; 44(4):413-8. PubMed ID: 8706307 [TBL] [Abstract][Full Text] [Related]
13. Inhibin forms in serum from postmenopausal women with ovarian cancers. Robertson DM; Cahir N; Burger HG; Mamers P; Groome N Clin Endocrinol (Oxf); 1999 Mar; 50(3):381-6. PubMed ID: 10435065 [TBL] [Abstract][Full Text] [Related]
14. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma. Welt CK; Lambert-Messerlian G; Zheng W; Crowley WF; Schneyer AL J Clin Endocrinol Metab; 1997 Nov; 82(11):3720-7. PubMed ID: 9360531 [TBL] [Abstract][Full Text] [Related]
15. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994 [TBL] [Abstract][Full Text] [Related]
16. Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer. Lambert-Messerlian GM; Steinhoff M; Zheng W; Canick JA; Gajewski WH; Seifer DB; Schneyer AL Gynecol Oncol; 1997 Jun; 65(3):512-6. PubMed ID: 9190984 [TBL] [Abstract][Full Text] [Related]
17. Oviductal glycoprotein (OVGP1, MUC9): a differentiation-based mucin present in serum of women with ovarian cancer. Maines-Bandiera S; Woo MM; Borugian M; Molday LL; Hii T; Gilks B; Leung PC; Molday RS; Auersperg N Int J Gynecol Cancer; 2010 Jan; 20(1):16-22. PubMed ID: 20130498 [TBL] [Abstract][Full Text] [Related]
18. Tumor-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA125) in patients with epithelial ovarian cancer. Peters-Engl C; Medl M; Ogris E; Leodolter S Anticancer Res; 1995; 15(6B):2727-30. PubMed ID: 8669854 [TBL] [Abstract][Full Text] [Related]
19. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma. Hasholzner U; Baumgartner L; Stieber P; Meier W; Hofmann K; Fateh-Moghadam A Anticancer Res; 1994; 14(6B):2743-6. PubMed ID: 7532929 [TBL] [Abstract][Full Text] [Related]
20. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors. Cathro HP; Stoler MH Hum Pathol; 2005 Feb; 36(2):195-201. PubMed ID: 15754297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]